Skip to content

To see the effect of drugs namely dashang guggulu and bilvadi kwath on obesity

A Comparative Study on the effect of Dashang Guggulu and Bilvadi Kwath in the management of sthaulya w.s.r. obesity.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/024405
Enrollment
60
Registered
2020-03-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E660- Obesity due to excess calories

Interventions

Intervention1: DASHANG GUGGULU: 500MG BD with Water for 3 months Intervention2: BILWADI KWATH: 50 ML BD for 3 months Control Intervention1: PLACEBO: 500MG BD with Water for 3 months

Sponsors

Ayurvedic and Unani Tibbia College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient willing to participate in the trial and sign the consent form. 2. The patients between the age group of 16 to 60 years in either sex.

Exclusion criteria

Exclusion criteria: 1. Patients who were not willing for trial. 2. Patient below the age of 16 years and above 60 years. 3. Patients suffering from stage II hypertension (>= 160/100 mmHg) and diabetic patient having FBS > 200 mg/dl. 4. Patient associated with major medical diseases like cancer, concurrent infection like tuberculosis etc. 5. Patients with genetic and endocrinal disorder, chronic disorder like paralysis, cancer, renal failure, hepatic failure & IHD. 6. Pregnant women

Design outcomes

Primary

MeasureTime frame
Improvement in Subjective SymptomsTimepoint: Patients will be assessed at 1 month interval for total 3 months

Secondary

MeasureTime frame
Improvement in Objective SymptomsTimepoint: Patients will be assessed at 1 month interval for total 3 months

Countries

India

Contacts

Public ContactDr Sujata Yadav

Ayurvedic and Unani Tibbia College and Hospital

sujatakcdelhi@gmail.com09810571653

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026